HBV Citations List: November 2022

Literature Citations

1. Design, Synthesis and Biological Evaluation of Novel Dihydrobenzodioxine Derivatives as HBV Capsid Protein Inhibitors. Liu, L., M. Wang, C. Li, X. Han, Y. Xie, K. Feng, L. Zhang, Y. Chen, and H. Jia. Bioorganic Chemistry, 2022. 128: 106052. PMID[35921789].
[PubMed]. HBV_11_2022.

2. Anti-Hepatitis B Virus Activity of Lithospermic acid, a Polyphenol from Salvia miltiorrhiza, in Vitro and in Vivo by Autophagy Regulation. Zhu, S., H. Wen, W. Wang, Y. Chen, F. Han, and W. Cai. Journal of Ethnopharmacology, 2023. 302(Pt A): 115896. PMID[36334815].
[PubMed]. HBV_11_2022.

3. Effects of Resveratrol on Hepatitis B Virus Replication: In Vitro and in Vivo Experiments. Pan, P., J. Li, W. Lin, and G. Long. Intervirology, 2022. 65(4): p. 206-214. PMID[36088911]. PMCID[PMC9677841].
[PubMed]. HBV_11_2022.

4. Design, Synthesis and Evaluation of Novel 4-(4-Chlorobenzyl)-6-methylpyridazin-3(2H)-one Derivatives as Hepatitis B Virus Inhibitors. Tan, O.U., J. Moncol, and D. Durantel. ChemistrySelect, 2022. 7(40): e202203164. ISI[000870768000001].
[WOS]. HBV_11_2022.

5. Discovery and Biological Evaluation of 2-((3-Phenylisoxazol-5-yl) methoxy) benzamide Derivatives as Potent Nucleocapsid Inhibitors. Xie, Z.Y., Z.C. Liang, Y.H. Huang, K.C. Shi, N. Zang, M. Wang, T.Y. Liang, and W.X. Wei. Journal of Molecular Structure, 2023. 1272: 134103. ISI[000869636900004].
[WOS]. HBV_11_2022.

Patent Citations

This month, no relevant HBV patents were identified.